Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leukemia. It is also developing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. The company has strategic alliances with Allogene Therapeutics, Inc.; Les Laboratoires Servier; The University of Texas M.D. Anderson Cancer Center; and Iovance Biotherapeutics, as well as a strategic research and development collaboration with Cytovia Therapeutics, Inc. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of CELLECTIS.
CELLECTIS business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of CELLECTIS are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of CELLECTIS , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of CELLECTIS including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of CELLECTIS and all latest updates of the company are provided.
The 2025 version of CELLECTIS report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 CELLECTIS- Key Facts
2.2 CELLECTIS- Geographic Locations
2.3 CELLECTIS- Subsidiaries and Affiliates
2.4 CELLECTIS- Business Divisions
2.5 CELLECTIS- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. CELLECTIS Strategic Analysis Review
3.1 CELLECTIS- Key Strategies
3.2 CELLECTIS- Company Outlook Statement
3.3 CELLECTIS- SWOT Analysis
3.3.1 CELLECTIS- Key Strengths
3.3.2 CELLECTIS- Key Weaknesses
3.3.3 CELLECTIS- Potential Opportunities
3.3.4 CELLECTIS- Potential Threats
3.4 CELLECTIS- Key Competitors
4. Business Description of the Company
4.1 CELLECTIS- Business Overview
4.2 CELLECTIS- Operations by Segment
5 Products and Services Details
5.1 CELLECTIS- Key Products
5.2 CELLECTIS- Key Service Areas
5.3 CELLECTIS- Key Brands
6 Company Developments
6.1 CELLECTIS- Company History
6.2 CELLECTIS- Latest Developments
7 Financial Analysis
7.1 CELLECTIS- Income Statements
7.2 CELLECTIS- Balance Sheet
7.3 CELLECTIS- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 CELLECTIS- Direct Competitors
8.2 CELLECTIS- Competitor Financial Ratios comparison
8.3 CELLECTIS- Competitor Stock Charts Comparison
8.4 CELLECTIS- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
